Insider Selling: Sangamo Biosciences CFO Unloads 15,000 Shares of Stock
Sangamo Biosciences CFO Henry Ward Wolff sold 15,000 shares of the company's stock in a transaction dated Thursday, July 10th.
Customer Interaction Solutions
Analysts Review Releases Notes on Alere, AMRI, Anika Therapeutics,...
On July 4, Analysts Review released its analysts' notes regarding Alere, Albany Molecular Research, Anika Therapeutics, Nektar Therapeutics and Sangamo Biosciences.
Sangamo Biosciences SVP Sells $234,900 in Stock
Sangamo Biosciences SVP Philip D. Gregory sold 15,000 shares of the company's stock in a transaction that occurred on Tuesday, July 1st.
Sangamo Biosciences Director Saira Ramasastry Sells 5,550 Shares
Sangamo Biosciences Director Saira Ramasastry unloaded 5,550 shares of Sangamo Biosciences stock on the open market in a transaction dated Monday, June 23rd.
Sangamo Biosciences CEO Edward O. Lanphier II Sells 25,000 Shares
Sangamo Biosciences CEO Edward O. Lanphier II sold 25,000 shares of the company's stock in a transaction dated Monday, June 16th.
Sangamo Biosciences Shares Down 4.5% After Insider Selling
Sangamo Biosciences 's share price dropped 4.5% on Wednesday after an insider sold shares in the company, Stock Ratings Network reports.
Sangamo BioSciences Announces Presentation At The 2014 JMP Securities Healthcare Conference
Sangamo BioSciences, Inc. announced today that Philip Gregory, D.Phil., Sangamo's senior vice president of research and CSO, will provide an update on the progress of Sangamo's ZFP Therapeutic development programs and an overview of the company's business strategy at 3:30 pm ET on Tuesday, June 24, 2014, at the 9th Annual JMP Securities Healthcare ... (more)